NEW YORK (GenomeWeb News) – Gentronix today said that it has received a French research tax credit approval for the years 2012-2014.

The credit allows eligible research-intensive French companies who are subject to corporate tax in France the ability to claim tax relief on costs generated in R&D requirements that are outsourced to Gentronix. The firm is based in Manchester, UK, and provides genotoxicity screening products and services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.